Diagnosis, treatment and prognosis of adult urinary rhabdomyosarcoma (Report of 8 cases and review of literature)
-
摘要: 目的:探讨成人泌尿系横纹肌肉瘤的病变特点及临床诊治方法。方法:回顾性分析8例成人泌尿系横纹肌肉瘤患者的临床资料:男6例,女2例,发病年龄18~47岁,平均29.1岁。肿瘤位于膀胱3例,前列腺2例,睾丸旁2例,肾脏1例。结果:本组8例均确诊为横纹肌肉瘤,其中6例行手术治疗,术后给予化疗或放疗,另2例单纯给予化疗。2例1年内死亡,2例2年内死亡,4例仍在随访中。结论:成人泌尿系横纹肌肉瘤属少见病,恶性程度高,进展快,大多数患者就诊时已属晚期,治疗效果差,早发现、早诊断、早治疗及以手术为主的综合治疗方式能取得较好效果。Abstract: Objective: To explore the characteristics, clinical diagnosis and treatment of adult urinary rhabdomyosarcoma.Method: A retrospective chart review was carried out for 8 adult patients diagnosed with urinary rhabdomyosarcoma:Six cases were male, two cases were femcle. The average age was 29.1(range from 18-47). Rhabdomy osarcoma was loated in bladder(3 cases), prostare(2 cases), testis(2 cases), kidney(1 cases) respectively.Result: The eight cases were confirmed for rhabdomyosarcoma, including 6 patients underwent surgery and had postoperative chemotherapy and/or radiotherapy, the other two patients only treated with chemotherapy. 2 cases died within 1 year, 2 cases died within 2 years, 4 patients still under follow-up.Conclusion: Adult urinary rhabdomyosarcoma is a rare disease with high malignancy. Because their early symptoms are not typical and progress fast, most diagnosed patients were at the advanced stage and had poor prognosis. Being early detection and early diagnosis, surgical resection with chemotherapy and/or radiotherapy was an effective way to achieve favorable outcomes.
-
Key words:
- urinary tumor /
- rhabdomyosarcoma /
- adult
-
-
[1] Breitfeld P P, Meyer W H. Rhabdomyosarcoma:new windows of opportunity[J]. Oncologist, 2005, 10:518-527.
[2] Newton WA Jr, Gehan E A, Webber B L, et al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an Intergroup Rhabdomyosarcoma Study[J]. Cancer, 1995, 76:1073-1085.
[3] Ferrer F A, Isakoff M, Koyle M A. Bladder/prostate rhabdomyosarcoma:past, present and future[J]. J Urol, 2006, 176:1283-1291.
[4] Michelagnoli M P, Burchill S A, Cullinane C, et al. Myogenin-a more specific target for RT-PCR detection of rhabdomyosarcoma than MyoD1[J]. Med Pediatr Oncol, 2003, 40:1-8.
[5] Sorensen P H, Lynch J C, Qualman S J, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma:a report from the children's oncology group[J]. J Clin Oncol, 2002, 20:2672-2679.
[6] Sharp R, Recio J A, Jhappan C, et al. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis[J]. Nat Med, 2002, 8:1276-1280.
[7] Ciarapica R, Russo G, Verginelli F, et al. Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma[J]. Cell Cycle, 2009, 8:172-175.
[8] Wang H, Garzon R, Sun H, et al. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma[J]. Cancer Cell, 2008, 14:369-381.
[9] Wu H Y, Snyder H M 3rd, Womer R B. Genitourinary rhabdomyosarcoma:which treatment, how much, and when[J]? J Pediatr Urol, 2009, 5:501-506.
-
计量
- 文章访问数: 28
- PDF下载数: 73
- 施引文献: 0